Analyst price target range
BioNTech Price Target: $120.35 Average
Direct answer
BioNTech's average price target is $120.35.
The verified analyst range runs from $75.79 to $144.59.
The low target implies -27%, the high target implies +39.3%, and the range spans 66.3% of the current price.
Forecast evidence checked September 7, 2026.
Get free BioNTech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $103.76
- Average price target
- $120.35
- High price target
- $144.59
- Low price target
- $75.79
- Low target gap
- -27%
- Target upside
- +16%
- High target gap
- +39.3%
- Target range width
- 66.3%
- Consensus rating
- Buy
- Analysts
- 20
- Evidence date
- September 7, 2026
- Valid through
- September 14, 2026
Explore related company data
Read the frequently asked questions.
What is BioNTech's average price target?
BioNTech's verified average price target is $120.35. The target range is $75.79 to $144.59.
How far are BioNTech's low and high targets from the recorded price?
The low target implies -27%, while the high target implies +39.3%.
How many analysts are included in BioNTech's consensus?
The verified consensus includes 20 analysts.
How is BioNTech's target upside or downside calculated?
The average target of $120.35 is divided by the recorded price of $103.76, then one is subtracted to produce +16%. This does not guarantee a future return.
When was BioNTech's analyst forecast verified?
The data was verified on 2026-09-07. The dataset is valid through 2026-09-14.